Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001214659-24-002876
Filing Date
2024-02-14
Accepted
2024-02-14 16:00:27
Documents
1
Group Members
KEVIN TANGTANG CAPITAL MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 o1172410sc13ga1.htm SC 13G/A 81561
  Complete submission text file 0001214659-24-002876.txt   83345
Mailing Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121 858-200-3830
TANG CAPITAL PARTNERS LP (Filed by) CIK: 0001191935 (see all company filings)

EIN.: 680517277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 611 GATEWAY BLVD., SUITE 273 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 273 SOUTH SAN FRANCISCO CA 94080 415-910-5717
Quince Therapeutics, Inc. (Subject) CIK: 0001662774 (see all company filings)

EIN.: 901024039 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91007 | Film No.: 24637381
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)